Infusion Business ExpansionThe company expects growth in its infusion business to exceed the broader infusion market's growth, leading to market share gains.
Revenue GrowthRevenue growth in 2026 is expected to be approximately twice as fast as the average of its home-based care peers, making the company deserving of a premium.
Specialty Pharmacy MomentumShares have performed strongly, driven primarily by impressive momentum in the Specialty Pharmacy business.